SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Dermata Therapeutics Reports Third-Quarter 2026 Financial Results

DRMA
SquawkNews Desk 1 updates Updated Nov 10, 2026, 09:11 PM UTC

Story updates

09:11:58 PM UTC
SquawkNews
Dermata generates product revenue following the launch of its first commercial product,Tome™ Foundational Treatment, on August 25, 2026 -- Tome Skincare ecommerce platform establishes a foundation for product growth through direct-to-consumer sales, subscriptions, and professional skincare channe…

Related stories

CoreWeave Q3 Revenue Jumps 168% to $3.66 Billion, Guidance Raised CoreWeave reported Q3 revenue of $3.66 billion, up 168% and above expectations, and raised its full-year guidance to at least $13 billion. M impact | EQUITY | Nov 10, 2026, 10:10 PM UTC US Stocks Fell as Hot Inflation Lifted Bond Yields US stocks fell on Tuesday after unexpectedly hot inflation drove bond yields higher and strengthened expectations for faster interest-rate increases. The move outweighed oil’s decl M impact | EQUITY | Nov 10, 2026, 10:00 PM UTC Tree Island Steel Reports C$45.6M Third-Quarter Revenue M impact | EQUITY | Nov 10, 2026, 10:00 PM UTC DRW Energy Closes $1 Billion Revolving Credit Facility DRW Energy closed an upsized $1 billion revolving credit facility arranged by Wells Fargo. M impact | EQUITY | Nov 10, 2026, 09:58 PM UTC Hyliion Holdings Q3 Revenue Beats Hyliion Holdings reported Q3 revenue above expectations. The headline cites progress on a US Navy contract but provides no contract details. M impact | EQUITY | Nov 10, 2026, 09:57 PM UTC Costco Declares $30 Special Dividend, Reauthorizes Buyback Costco declared a $30 special cash dividend and reauthorized its stock repurchase program. M impact | EQUITY | Nov 10, 2026, 09:54 PM UTC